Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaemin Lim

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
International Journal of Nanomedicine|March 9, 2016
Development of a robust pH-sensitive polyelectrolyte ionomer complex for anticancer nanocarriersChaemin Lim, Yu Seok Youn, Kyung Soo Lee, et al.
International Journal of Nanomedicine|September 9, 2017
A charge-reversible nanocarrier using PEG-PLL (-<i>g</i>-Ce6, DMA)-PLA for photodynamic therapyChaemin Lim, Taehoon Sim, Ngoc Ha Hoang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 23, 2023
Development and characterization of pH-responsive nanocarriers for chemo-photothermal combination therapy of acidic tumorsPatihul Husni, Yuseon Shin, Hyewon Jeon, et al.
Biomaterials|August 10, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
ACS Combinatorial Science|March 6, 2013
Column chromatography-free solution-phase synthesis of a natural piper-amide-like compound librarySumin Kim, Chaemin Lim, Sukjin Lee, et al.
International Journal of Pharmaceutics|October 7, 2017
HM10660A, a long-acting hIFN-α-2b, is a potent candidate for the treatment of hepatitis C through an enhanced biological half-lifeSungmin Bae, Taehoon Sim, Chaemin Lim, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
International Journal of Nanomedicine|June 14, 2019
A nano-sized blending system comprising identical triblock copolymers with different hydrophobicity for fabrication of an anticancer drug nanovehicle with high stability and solubilizing capacityNgoc Ha Hoang, Taehoon Sim, Chaemin Lim, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 productionChaemin Lim, Minhee Lee, Eun-Jung Park, et al.
AAPS Pharmscitech|September 24, 2024
Development and Characterization of Olaparib-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Pharmaceutical ApplicationsYuseon Shin, Mikyung Kim, Chaeyeon Kim, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
International Journal of Nanomedicine|March 9, 2016
Development of a robust pH-sensitive polyelectrolyte ionomer complex for anticancer nanocarriersChaemin Lim, Yu Seok Youn, Kyung Soo Lee, et al.
International Journal of Nanomedicine|September 9, 2017
A charge-reversible nanocarrier using PEG-PLL (-<i>g</i>-Ce6, DMA)-PLA for photodynamic therapyChaemin Lim, Taehoon Sim, Ngoc Ha Hoang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 23, 2023
Development and characterization of pH-responsive nanocarriers for chemo-photothermal combination therapy of acidic tumorsPatihul Husni, Yuseon Shin, Hyewon Jeon, et al.
Biomaterials|August 10, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
ACS Combinatorial Science|March 6, 2013
Column chromatography-free solution-phase synthesis of a natural piper-amide-like compound librarySumin Kim, Chaemin Lim, Sukjin Lee, et al.
International Journal of Pharmaceutics|October 7, 2017
HM10660A, a long-acting hIFN-α-2b, is a potent candidate for the treatment of hepatitis C through an enhanced biological half-lifeSungmin Bae, Taehoon Sim, Chaemin Lim, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2024
Tumor microenvironment immunomodulation by nanoformulated TLR 7/8 agonist and PI3k delta inhibitor enhances therapeutic benefits of radiotherapyMostafa Yazdimamaghani, Oleg V Kolupaev, Chaemin Lim, et al.
International Journal of Nanomedicine|June 14, 2019
A nano-sized blending system comprising identical triblock copolymers with different hydrophobicity for fabrication of an anticancer drug nanovehicle with high stability and solubilizing capacityNgoc Ha Hoang, Taehoon Sim, Chaemin Lim, et al.
Bioorganic & Medicinal Chemistry Letters|October 26, 2010
Sulfonamide derivatives of styrylheterocycles as a potent inhibitor of COX-2-mediated prostaglandin E2 productionChaemin Lim, Minhee Lee, Eun-Jung Park, et al.
AAPS Pharmscitech|September 24, 2024
Development and Characterization of Olaparib-Loaded Solid Self-Nanoemulsifying Drug Delivery System (S-SNEDDS) for Pharmaceutical ApplicationsYuseon Shin, Mikyung Kim, Chaeyeon Kim, et al.
Pageof 7